Delivery Order SPE2DB20D3505-SPE2DB22FU2X7

Award Date 9/9/22
Potential Completion Date 9/12/22
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of Phytonadione 1 mg/0.5 ml syrup, a specialty pharmaceutical product, with a ceiling value of $9,491.65 and a period of performance through March 27, 2024. This is a firm fixed price delivery order contract, with no set-aside designation....
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $3,679.40 contract is for the supply of phytonadione 1 mg/0.5 ml syrups. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $14,430.66, is for the delivery of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of medical supplies such as phytonadione 10mg (vitamin K) to the U.S. government. The contract, valued at $7,648.66, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The DLA IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award (SPE2DB24D2100|SPE2DB25FBBKQ) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,120.54 firm fixed-price delivery order is for the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $59,040.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product 4559504658 ! PHYTNDIN 5MG TBL 100S. It is a firm fixed-price contract with a period of performance through February 2, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FEBA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,058.47 firm fixed-price delivery order is for the supply of Phytonadione 1 mg/0.5 ml syrup, 0.5 ml, with a period of performance through March 4, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award SPE2DB22D2206|SPE2DB24FHD48 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,314.90 delivery order contract is for the supply of PHYTONADIONE 5 MG TABLET 100S, a prescription drug product. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $20,364.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract provides for the delivery of phytonadione 1 mg/0.5 ml syrup in 0.5 ml doses to support...
This federal contract award, valued at $110,294.34, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. The contract has an ultimate completion date of October 10, 2023. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB22FU2X7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Phytonadione 5 mg tablets, valued at $12,969.83. The contract is a Firm Fixed Price Delivery Order with a completion date of September 12, 2022.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:07 AM